Press Releases on February 28, 2018

ProQR Announces Results for the Fourth Quarter and Full Year 2017 and Provides Business Update

Key updates Runway into the second half of 2019: cash of €48.0 million at year-end expected to fund operations through anticipated clinical data readouts in three different programs. First patient dosed in the Phase 1/2 safety & efficacy trial for …

Novelion Therapeutics Observes Rare Disease Day

VANCOUVER, British Columbia, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ:NVLN), a biopharmaceutical company dedicated to developing new standards of care for individuals living with rare diseases, today announced its alliance with …

Cara Therapeutics Doses First Patient in Phase 1 Trial of Oral KORSUVA™ (CR845/difelikefalin) in Chronic Liver Disease (CLD) ...

STAMFORD, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting …

Horizon Pharma plc Announces Fourth-Quarter and Full-Year 2017 Results

-- Fourth-Quarter 2017 Net Sales of $274.2 Million; Fourth-Quarter 2017 Net Loss of $46.4 Million; Adjusted EBITDA of $102.7 Million -- -- Fourth-Quarter 2017 Operating Cash Flow of $143.2 Million; Fourth-Quarter 2017 Non-GAAP Operating Cash Flow of $157.9 …

Akcea Therapeutics Recognizes Rare Disease Day by Spotlighting Several Historic “Firsts” for People Living with Familial ...

CAMBRIDGE, Mass., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid …

Melinta Therapeutics To Report Fourth Quarter and Full Year 2017 Financial Results on March 13, 2018

NEW HAVEN, Conn., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, announced today it intends to release its …

Trevena to Host Conference Call on March 7th to Discuss Full Year 2017 Financial Results

CHESTERBROOK, Pa., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ:TRVN) today announced that it will host a conference call on Wednesday, March 7, 2018 at 8:00 am EST to review financial results as of and for the quarter and year ended December 31 …

Lexicon Pharmaceuticals Announces Poster Presentation at the 15th Annual ENETS Conference

THE WOODLANDS, Texas, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), announced today that data from a poster highlighting XERMELO® (telotristat ethyl) will be presented at the upcoming 15th Annual European Neuroendocrine …

Amicus Therapeutics Announces Full-Year 2017 Financial Results and 2018 Corporate Updates

Galafold Expansion Continues with 360+ Fabry Patients Treated Today - on Track to Achieve FY18 Revenue Guidance of $75M-$85M Significant Progress Across Pompe Clinical, Regulatory and Manufacturing Activities - Successfully Completed First GMP …

VitalHub Subsidiary HInext Adds 16 New Customers in New York State

TORONTO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX-V:VHI) is pleased to announce that its subsidiary HInext Inc. (“HInext”) has obtained 16 new customers in New York State, through the BH-IT funding program for …

Snipp Announces $500,000 Investment From Asian Strategic Investor

TORONTO, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Snipp Interactive Inc. ("Snipp" or the “Company”) (OTCQB: SNIPF) (TSX-V: SPN), a global provider of digital marketing promotions, rebates and loyalty solutions, is pleased to announce the closing of the …

Evogene Reports Fourth Quarter and Full Year 2017 Financial Results

REHOVOT, Israel, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company developing novel products for life science markets through the use of a unique Computational Predictive Biology (CPB) platform, …

Radar Market Growing at a CAGR of 8.3% by 2027- Future Market Insights

VALLEY COTTAGE, NY, Feb. 28, 2018 (GLOBE NEWSWIRE) -- A new report published by Future Market Insights (FMI) titled “Radar Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” states that with the increasing focus of …

Global Indexbased Agricultural Insurance Market 2018 – Industry Analysis, Size, Share, Strategies and Forecast to 2022

PUNE, INDIA, February 28, 2018 /⁨EINPresswire.com⁩/ -- Indexbased Agricultural Insurance Market 2018 Wiseguyreports.Com adds “Indexbased Agricultural Insurance Market –Market Demand, Growth, Opportunities, Analysis of Top Key Players and Forecast to …

Porsche is reducing CO2 emissions thanks to sustainable logistics transport

Rugby Kenya Cup: Strathmore, Nakuru tussle for final Kenya Cup playoff slot

Three points separate sixth placed Strathmore Leos (25 points) from seventh placed Top Fry Nakuru (22 points) as the quest for the last Kenya Cup playoff slot goes down to the wire with the last round of action in the competition’s league phase on Saturday …

Roaring to life: Growth and innovation in African retail banking

The McKinsey Global Banking (www.McKinsey.com) practice has today published a new report on African Retail Banking - Roaring to life: Growth and innovation in African retail banking (https://goo.gl/grn5ju).  The report finds that Africa’s banking markets …

Dougherty’s Pharmacy, Inc. Announces New Location at The Campus at Legacy West in Plano

DALLAS, Feb. 28, 2018 (GLOBE NEWSWIRE) -- Dougherty’s Pharmacy, Inc. (the “Company” or “Dougherty’s”) (OTCQB:MYDP) today announced that it has opened a new retail pharmacy location at The Campus at Legacy West in Plano, Texas.  This new location will offer …

Emergent BioSolutions Awarded One-Year CDC Contract Valued at $26 Million for Vaccinia Immune Globulin Program

GAITHERSBURG, Md., Feb. 28, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced a contract award by the Centers for Disease Control and Prevention (CDC) valued at $26 million over 12 months for the continued supply of Vaccinia …

Ghanaian Defense Industry : The Market is Expected to Gorw at CAGR of 9.31% During Forecast Period

PUNE, MAHARASHTRA, INDIA, February 28, 2018 /⁨EINPresswire.com⁩/ -- Ghanaian Defense Industry Overview The Future of the Ghanaian Defense Industry - Market Attractiveness, Competitive Landscape and Forecasts to 2022, report, provides readers …